TY - JOUR
T1 - Serum cytokine responses during acute human granulocytic ehrlichiosis
AU - Dumler, J. S.
AU - Trigiani, E. R.
AU - Bakken, J. S.
AU - Aguero-Rosenfeld, M. E.
AU - Wormser, G. P.
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2000/1
Y1 - 2000/1
N2 - Human granulocytic ehrlichiosis (HGE) is caused by obligate intracellular bacteria in the Ehrlichia phagocytophila group. The disease ranges from subclinical to fatal. We speculated that cell-mediated immunity would be important for recovery from and potentially in the clinical manifestations of HGE; thus, serum tumor necrosis factor alpha (TNF-α), interleukin 1β (IL-1β), gamma interferon (IFN-γ), IL-10, and IL-4 concentrations were studied. IFN-γ (1,035 ± 235 pg/ml [mean ± standard error of the mean]) and IL-10 (118 ± 46 pg/ ml) concentrations were elevated in acute-phase sera versus convalescent sera and normal subjects (P ≤ 0.013 and P ≤ 0.018, respectively). TNF-α, IL-1β, and IL-4 levels were not elevated. Cytokine levels in severely and mildly affected patients were not different. HGE leads to induction of IFN-γ-dominated cell-mediated immunity associated with clinical manifestations, recovery from infection, or both.
AB - Human granulocytic ehrlichiosis (HGE) is caused by obligate intracellular bacteria in the Ehrlichia phagocytophila group. The disease ranges from subclinical to fatal. We speculated that cell-mediated immunity would be important for recovery from and potentially in the clinical manifestations of HGE; thus, serum tumor necrosis factor alpha (TNF-α), interleukin 1β (IL-1β), gamma interferon (IFN-γ), IL-10, and IL-4 concentrations were studied. IFN-γ (1,035 ± 235 pg/ml [mean ± standard error of the mean]) and IL-10 (118 ± 46 pg/ ml) concentrations were elevated in acute-phase sera versus convalescent sera and normal subjects (P ≤ 0.013 and P ≤ 0.018, respectively). TNF-α, IL-1β, and IL-4 levels were not elevated. Cytokine levels in severely and mildly affected patients were not different. HGE leads to induction of IFN-γ-dominated cell-mediated immunity associated with clinical manifestations, recovery from infection, or both.
UR - http://www.scopus.com/inward/record.url?scp=0033964215&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033964215&partnerID=8YFLogxK
U2 - 10.1128/cdli.7.1.6-8.2000
DO - 10.1128/cdli.7.1.6-8.2000
M3 - Article
C2 - 10618268
AN - SCOPUS:0033964215
VL - 7
SP - 6
EP - 8
JO - Clinical and Diagnostic Laboratory Immunology
JF - Clinical and Diagnostic Laboratory Immunology
SN - 1071-412X
IS - 1
ER -